Literature DB >> 29236562

From Narcotic to Normalizer: The Misperception of Methadone Treatment and the Persistence of Prejudice and Bias.

Joycelyn Sue Woods1,2,3, Herman Joseph4,3.   

Abstract

This article concentrates on methadone maintenance as a normalizer for the impairments of opioid addiction, and the misunderstandings of it as a substitute for heroin that continues an opiate addiction. Methadone treatment was developed by Drs. Dole, Nyswander, and Kreek. Their cutting-edge theory transformed the way that opioid addiction is perceived and their work changed methadone from a narcotic to withdraw addicts to a medication that is a maintenance normalizer for a chronic condition. Their extensive research involved the physiological and sociological normalizing effects of methadone and medical safety of the medication (Dole & Nyswander, 1967).

Entities:  

Keywords:  Metabolic theory; methadone treatment; narcotic blockade; prejudice; substituting one addiction for another

Mesh:

Substances:

Year:  2017        PMID: 29236562     DOI: 10.1080/10826084.2017.1400068

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  7 in total

Review 1.  Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.

Authors:  Chloe J Jordan; Jianjing Cao; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-04-19       Impact factor: 5.250

2.  The "black box" of treatment: Patients' perspective on what works in opioid maintenance treatment for opioid dependence.

Authors:  Teresa C Silva; Fredrik B Andersson
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-05-10

3.  Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees.

Authors:  Lauren A Hoffman; Corrie L Vilsaint; John F Kelly
Journal:  J Subst Abuse Treat       Date:  2021-05-08

4.  Predictive Factors of Treatment Outcomes for Hospital Care in Children with Acute Methadone Poisoning.

Authors:  Yasamin Atighi; Nastaran Eizadi-Mood; Marjan Mansourian; Amin Zamani; Ali Saffaei; Ali Mohammad Sabzghabaee
Journal:  J Res Pharm Pract       Date:  2018 Oct-Dec

5.  Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders.

Authors:  Juan J Ruíz Ruíz; José M Martinez Delgado; Nuria García-Marchena
Journal:  Harm Reduct J       Date:  2021-04-13

Review 6.  A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder.

Authors:  Alina Cernasev; Kenneth C Hohmeier; Kelsey Frederick; Hilary Jasmin; Justin Gatwood
Journal:  Explor Res Clin Soc Pharm       Date:  2021-06-04

7.  Opioid Use Disorders in People Living with HIV/AIDS: A Review of Implications for Patient Outcomes, Drug Interactions, and Neurocognitive Disorders.

Authors:  Alina Cernasev; Michael P Veve; Theodore J Cory; Nathan A Summers; Madison Miller; Sunitha Kodidela; Santosh Kumar
Journal:  Pharmacy (Basel)       Date:  2020-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.